Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease
management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435
Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
The True Overall Mortality of Unselected Nephropathic Type 2 Diabetic Patients With Mild to Moderate Renal Insufficiency Diabetes Care May 2003 26:1639-1640; doi:10.2337/diacare.26.5.1639
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518
Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease
management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No! Diabetes Care May 2003 26:1615-1618; doi:10.2337/diacare.26.5.1615
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333
Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy Diabetes Care May 2003 26:1589-1596; doi:10.2337/diacare.26.5.1589
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485
Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648
Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy
Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652
Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy
Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
Complete Blockade of the Renin-Angiotensin System in Patients With Advanced Diabetic Nephropathy Diabetes Care May 2003 26:1635-1636; doi:10.2337/diacare.26.5.1635-a
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369
A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Roze, Palmer, and Valentine Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659
Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
The True Overall Mortality of Unselected Nephropathic Type 2 Diabetic Patients With Mild to Moderate Renal Insufficiency Diabetes Care May 2003 26:1639-1640; doi:10.2337/diacare.26.5.1639
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Diabetes and Telemedicine: Is the technology sound, effective, cost-effective, and practical? Diabetes Care May 2003 26:1626-1628; doi:10.2337/diacare.26.5.1626
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease
management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435
Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes Diabetes Care May 2003 26:1597-1605; doi:10.2337/diacare.26.5.1597
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654
IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy
Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518
The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes Diabetes Care May 2003 26:1597-1605; doi:10.2337/diacare.26.5.1597
A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy
Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
The Relation Between Physical Activity and Metabolic Control in Type 2 Diabetes With <20 Years of Evolution Diabetes Care May 2003 26:1648-1650; doi:10.2337/diacare.26.5.1648
Dermatophyte Test Medium Culture for Evaluating Toenail Infections in Patients With Diabetes Diabetes Care May 2003 26:1480-1484; doi:10.2337/diacare.26.5.1480
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy
Diabetes Care May 2003 26:1652-1653; doi:10.2337/diacare.26.5.1652
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women Diabetes Care May 2003 26:1413-1420; doi:10.2337/diacare.26.5.1413
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance Diabetes Care May 2003 26:1333-1337; doi:10.2337/diacare.26.5.1333
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care May 2003 26:1485-1489; doi:10.2337/diacare.26.5.1485
Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners
in Diabetic Patients: An intervention trial Diabetes Care May 2003 26:1497-1500; doi:10.2337/diacare.26.5.1497
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Effect of 2-Week Treatment With Pirenzepine on Fasting and Postprandial Glucose Concentrations in Individuals With Type 2
Diabetes Diabetes Care May 2003 26:1636-1637; doi:10.2337/diacare.26.5.1636
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care May 2003 26:1513-1517; doi:10.2337/diacare.26.5.1513
Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Lipid Testing Among Patients With Diabetes Who Receive Diabetes Care From Primary Care Physicians Diabetes Care May 2003 26:1369-1373; doi:10.2337/diacare.26.5.1369
Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes: Bring on the heavy weights Diabetes Care May 2003 26:1580-1588; doi:10.2337/diacare.26.5.1580
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Roze, Palmer, and Valentine Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659
Improved Insulin Sensitivity and Metabolic Control in Type 2 Diabetes Does Not Influence Plasma Homocysteine Diabetes Care May 2003 26:1637-1639; doi:10.2337/diacare.26.5.1637
Diabetes and Coronary Artery Bypass Surgery: An examination of perioperative glycemic control and outcomes Diabetes Care May 2003 26:1518-1524; doi:10.2337/diacare.26.5.1518
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care May 2003 26:1501-1506; doi:10.2337/diacare.26.5.1501
IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes: Response to Conti et al. Diabetes Care May 2003 26:1654-1655; doi:10.2337/diacare.26.5.1654
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime Diabetes Care May 2003 26:1490-1496; doi:10.2337/diacare.26.5.1490
Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease
management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care May 2003 26:1427-1434; doi:10.2337/diacare.26.5.1427
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395
Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients Diabetes Care May 2003 26:1525-1529; doi:10.2337/diacare.26.5.1525
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
A Multivariate Logistic Regression Equation to Screen for Diabetes: Response to Tabaei and Herman Diabetes Care May 2003 26:1658-1659; doi:10.2337/diacare.26.5.1658
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III
Definition of the Metabolic Syndrome: Results from a population-based survey Diabetes Care May 2003 26:1635; doi:10.2337/diacare.26.5.1635
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy Diabetes Care May 2003 26:1540-1544; doi:10.2337/diacare.26.5.1540
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care May 2003 26:1338-1343; doi:10.2337/diacare.26.5.1338
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b
Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study Diabetes Care May 2003 26:1449-1455; doi:10.2337/diacare.26.5.1449
Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care May 2003 26:1507-1512; doi:10.2337/diacare.26.5.1507
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Importance of Obtaining Independent Measures of Insulin Secretion and Insulin Sensitivity During the Same Test: Results with the Botnia clamp Diabetes Care May 2003 26:1395-1401; doi:10.2337/diacare.26.5.1395
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to Yoshioka, Yoshida, and Yoshikawa Diabetes Care May 2003 26:1659-1660; doi:10.2337/diacare.26.5.1659-b
Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes: Bring on the heavy weights Diabetes Care May 2003 26:1580-1588; doi:10.2337/diacare.26.5.1580
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study Diabetes Care May 2003 26:1374-1379; doi:10.2337/diacare.26.5.1374
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al. Diabetes Care May 2003 26:1657-1658; doi:10.2337/diacare.26.5.1657
Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes Diabetes Care May 2003 26:1356-1361; doi:10.2337/diacare.26.5.1356
Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity Diabetes Care May 2003 26:1462-1467; doi:10.2337/diacare.26.5.1462
Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care May 2003 26:1344-1349; doi:10.2337/diacare.26.5.1344
Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease
management cohort Diabetes Care May 2003 26:1435-1438; doi:10.2337/diacare.26.5.1435
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism
Diabetes Care May 2003 26:1647-1648; doi:10.2337/diacare.26.5.1647-a
Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type
2 Diabetes Diabetes Care May 2003 26:1642-1643; doi:10.2337/diacare.26.5.1642
Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care May 2003 26:1643-1644; doi:10.2337/diacare.26.5.1643
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a
β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes: Response to van Tilburg et al. Diabetes Care May 2003 26:1659; doi:10.2337/diacare.26.5.1659-a
A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020
Diabetes Care May 2003 26:1545-1552; doi:10.2337/diacare.26.5.1545
Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al. Diabetes Care May 2003 26:1656-1657; doi:10.2337/diacare.26.5.1656
Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care May 2003 26:1439-1448; doi:10.2337/diacare.26.5.1439
Stages of Change for Healthy Eating in Diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors Diabetes Care May 2003 26:1468-1474; doi:10.2337/diacare.26.5.1468
IGF-1 and Macrovascular Complications of Diabetes: Alternative interpretations of recently published data Diabetes Care May 2003 26:1653-1654; doi:10.2337/diacare.26.5.1653
Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison
to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care May 2003 26:1456-1461; doi:10.2337/diacare.26.5.1456